Supplimentary Figure S2: Kaplan-Meier curves estimation of DFS and OS for patients with high or low methylation levels stratified by tumor stage or the receipt of concurrent chemotherapy from Genome-Wide Identification of a Methylation Gene Panel as a Prognostic Biomarker in Nasopharyngeal Carcinoma

Kaplan-Meier curves estimation of disease-free survival (DFS) and overall survival (OS) for patients with high or low methylation levels stratified by tumor stage or the receipt of concurrent chemotherapy.